Osteonecrosis News and Research

RSS
Vitamin D and calcium improves bone density in male veterans treated with AEDs

Vitamin D and calcium improves bone density in male veterans treated with AEDs

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Nanodiamonds could be used to promote bone growth and durability of dental implants

Nanodiamonds could be used to promote bone growth and durability of dental implants

Study shows patients with avascular necrosis have turned to stem cell therapy for aid

Study shows patients with avascular necrosis have turned to stem cell therapy for aid

Xgeva receives FDA approval for treating giant cell tumor of the bone

Xgeva receives FDA approval for treating giant cell tumor of the bone

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Medication use and doctor visits drive up jaw necrosis-related costs

Medication use and doctor visits drive up jaw necrosis-related costs

Perthes’ disease link to congenital disorders revealed

Perthes’ disease link to congenital disorders revealed

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Caltech-led team discovers enzyme responsible for neural crest cell development

Caltech-led team discovers enzyme responsible for neural crest cell development

Bisphosphonates increase risk for bone disease after tooth extraction

Bisphosphonates increase risk for bone disease after tooth extraction

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

Age at onset influences juvenile dermatomyositis course

Age at onset influences juvenile dermatomyositis course

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Simple interventions boost vertebral fracture osteoporosis care

Simple interventions boost vertebral fracture osteoporosis care

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Bisphosphonate benefit for breast cancer yet to be proven

Bisphosphonate benefit for breast cancer yet to be proven

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.